<DOC>
	<DOCNO>NCT00507715</DOCNO>
	<brief_summary>The purpose trial study effect association levodopa/carbidopa plantago ovata husk Parkinson´s disease patient recent diagnostic , treated levodopa/carbidopa .</brief_summary>
	<brief_title>Study Modification Pharmacokinetic Profile Levodopa Fiber Plantago Ovata Husk</brief_title>
	<detailed_description>Although treatment l-dopa election treatment Parkinson´s disease , high number patient develop motor complication , include , fluctuation dyscinesia year treatment . The origin fluctuation well establish , could attribute , al least partially , pharmacokinetics factor . So , could improve answer reduce adverse reaction reach stable level L-dopa circulation . The first experimental study animal show Plantago ovata husk influence pharmacokinetics parameter L-dopa , obtain stable level .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Patients diagnostic idiopathic Parkinson disease , well control symptomatology administration ldopa/carbidopa . At least 3 month treatment continue levodopa . Patients give consent participate study . Patients diagnostic idiopathic Parkinson disease , bad control symptomatology administration ldopa/carbidopa . Patients allergic predisposition Plantago ovata husk contraindication use .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Parkinson 's Disease , Idiopathic</keyword>
	<keyword>l-dopa level</keyword>
	<keyword>plantago ovata husk</keyword>
</DOC>